J&J Hip Replacement Plaintiff Lawyers Named by Judge

From Bloomberg: Six plaintiffs’ lawyers will lead federal litigation against Johnson & Johnson over recalled devices used in hip-replacement surgeries. U.S. District Judge David A. Katz in Toledo, Ohio, appointed the plaintiffs’ executive committee on Jan. 26 after dozens of lawyers vied for the positions. The group will make major decisions on the litigation, which […]

January 31, 2011

From Bloomberg:

Six plaintiffs’ lawyers will lead federal litigation against Johnson & Johnson over recalled devices used in hip-replacement surgeries.

U.S. District Judge David A. Katz in Toledo, Ohio, appointed the plaintiffs’ executive committee on Jan. 26 after dozens of lawyers vied for the positions. The group will make major decisions on the litigation, which has been consolidated before Katz for pretrial proceedings.

Lawyers for patients said they expect thousands of lawsuits over the ASR XL Acetabular System, which J&J’s DePuy Orthopaedics unit recalled on Aug. 26.

New Brunswick, New Jersey-based J&J, the world’s largest health-care products company, and Warsaw, Indiana-based DePuy said they recalled the devices because researchers found some patients needed a second operation, or “revision surgery,” after five years at rates higher than the company expected.

“There is no doubt there will be thousands of cases,” said the committee’s co-lead counsel, attorney Ellen Relkin of Weitz & Luxenberg in New York. “The damages will be in the billions of dollars.”

The group includes Christopher Seeger of Seeger Weiss LLP in New York.

Notwithstanding claims relating to this product, the drug/medical device remains approved by the U.S. FDA.

 

Related News

March 12, 2026
Seeger Weiss Partner Parvin Aminolroaya and Counsel Max Kelly Appointed to Leadership Roles in GLP-1 NAION Products Liability Litigation

Seeger Weiss is proud to announce that Partner Parvin Aminolroaya has been appointed Co-Lead Counsel for Plaintiffs in the In Re: GLP-1 RAS Non-arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation and Counsel Max Kelly has been appointed to the Plaintiffs’ Executive Committee. The litigation involves claims that GLP-1 receptor agonist drugs including Ozempic, Wegovy, […]

Read More
February 18, 2026
Twelve Seeger Weiss Attorneys Named to The 2026 Lawdragon 500 Leading Plaintiff Consumer Lawyers Guide

Seeger Weiss is proud to announce that twelve Seeger Weiss attorneys have been selected for inclusion in the 2026 Lawdragon 500 Leading Plaintiff Consumer Lawyers guide. Congratulations to Christopher Seeger, Stephen Weiss, Parvin K. Aminolroaya, Ben Barnett, David R. Buchanan, Steven Daroci, Scott Alan George, Shauna Itri, Diogenes P. Kekatos, Michael L. Rosenberg, Jennifer Scullion, […]

Read More
February 17, 2026
$7.25 Billion Nationwide Roundup / Glyphosate Class Action Settlement To Provide Compensation To Those Diagnosed With Non-Hodgkin Lymphoma After Exposure To Weedkiller

ST. LOUIS, MO – A proposed nationwide class-action settlement resolving claims that exposure to Roundup herbicides caused non-Hodgkin lymphoma (NHL) was filed today in the 22nd Judicial Circuit Court for the City of St. Louis, Missouri. The settlement would make up to $7.25 billion available to compensate individuals across the United States who were exposed […]

Read More